Guidance Cracks Under Execution Drag

Capacite reaffirmed its 20% revenue growth guidance for FY27 despite Q1 delivering only 6.7% YoY—a 13-point miss that forced management to frame the full year as a ramp story. To hit the guided target, H2 must average roughly 28% growth, a pace the company has not sustained in recent quarters. Meanwhile, net profit fell 15.2% YoY to ₹40 Cr, margin compressed by ₹10 Cr in commodity price provisions and a higher share of early-phase project work. The result is a credibility gap: guided growth well on track (per the call), yet the operational data suggests execution remains constrained.

The quarter was hit by four specific project delays: IIT Bombay (₹550 Cr contract) delayed by tree-cut permits, expected to yield ₹65–70 Cr in Q1–Q2 revenue but started only in Q2; NBCC project late to profit ramp (only now ramping to ₹60 Cr/month); CIDCO residential (₹2,500 Cr, one of the largest orders) with only 2 of 7 locations handed over; and MHADA (TCC JV) at ₹20 Cr/month vs full capacity target of ₹75+ Cr by Q3. On the call, management attributed these delays to client sequencing, permitting, and labor shortages (resolved by June). While order book stands at a robust ₹13,535 Cr (5.4x annualized Q1 revenue), the conversion timeline has slipped across the board. The risk: these same external and client-side constraints may not fully dissolve in H2, and management has given no signal of internal mitigation (faster approvals, parallel workflows, cost controls).

Revenue grew 6.7%, but PAT fell 15.2%—a red flag for profitability. EBITDA margin compressed 150 basis points YoY (17.2% → 15.7%), driven by two factors: (1) ₹10 Cr in commodity price provisions (adding to ₹10 Cr in Q4), hedging aluminum and copper exposure where price inflation has lagged the escalation indices used in contracts; and (2) a higher share of early-phase work on new projects (IIT, NBCC, MHADA), which carry lower margins until construction accelerates. Management hopes to reverse a 'substantial portion' of the ₹20 Cr total provision in Q3–Q4 as government escalation indices catch up to actual material costs. But indices have already lagged for three months, and management has not hedged prices or locked forward rates—a sign of passive management of margin risk. If indices don't move, further provisions are likely.

Order backlog of ₹13.5K Cr is real and 55% public, 45% private—a diversified pipeline. Bid pipeline for H2 is ₹27K Cr (₹22K public, ₹5K private), and management targets ₹4,500–5,000 Cr in order inflow for FY27. Historical execution (CAGR 2022–26 ≈18–20% consol; PAT CAGR >40% prior years) shows the company CAN convert large orders. Major projects are now active: IIT execution started Q2, NBCC ramping to ₹60 Cr/month, CIDCO handovers accelerating Q2–Q3. The four-quarter debt-free plan is credible given working capital improvements (43 days reduction last year, targeting 25–30 days this year). Promoter is trimming pledges, signaling conviction. If H2 projects execute to plan, the 20% target is achievable.

Revenue growth is decelerating despite a growing order book: 22% (FY25) → 12% (FY26) → 6.7% (Q1 FY27). To hit 20% for the full year, H2 must average 28%—a pace the company has not sustained in any recent period. PAT growth is negative (−15.2% YoY) despite revenue growth, signaling structural margin compression, not just timing. The ₹20 Cr in commodity provisions is speculative on reversal; if escalation indices remain sticky, further provisions or margin cuts are likely. Contract assets are 78% of revenue vs peers at 56–65%, indicating slow cash conversion and high working capital intensity. All major projects started late (IIT, NBCC, CIDCO, MHADA), and management blamed only externals (permits, labor, client sequencing)—no accountability for internal execution gaps. Finally, management reaffirmed guidance without showing a credible H2 roadmap (no Q2 preliminary data, no detailed project timeline disclosed). This defensive posture, combined with the large gap between guidance and Q1 delivery, suggests management is hoping, not planning, for a turnaround.

The stock closed ₹214.53 on August 14, down 31.73% from its all-time high of ₹314.25 and trading below all major moving averages (SMA20 ₹215.96, SMA50 ₹229.11, SMA200 ₹241.81). The market's reaction to the Q1 result was muted disappointment: day-1 decline of 0.98%, followed by day-3 at −1.67% and day-5 at +0.91%. The minimal recovery by day-5 suggests the market has priced in execution concern and is holding the down move—not a capitulation sale, but a steady retrenchment. Volume is normal, RSI at 45.5 (neutral, not oversold), indicating the stock is not yet a true bottom-fishing candidate.

Institutional flows are cautious. FII ownership has trimmed 80 basis points QoQ to 14.16% (from 14.96%), signaling foreign institutions are taking risk off. DII is flat at 7.72%, showing domestic institutions are not accumulating aggressively. Promoter holdings remain stable at 31.69%, though the ongoing pledge release (from 85.5 lakh to 50 lakh shares by March 2027) shows the promoter is trimming leverage, not increasing conviction. This divergence—stable at the top, trimming in the middle—is a classic sign of a stock losing institutional momentum.